Logo image of QNCX

QUINCE THERAPEUTICS INC (QNCX) Stock Analyst Ratings

NASDAQ:QNCX - Nasdaq - US22053A1079 - Common Stock - Currency: USD

1.17  +0.04 (+3.54%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.4. This target is 532.05% above the current price.
QNCX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about QNCX.
In the previous month the buy percentage consensus was at a similar level.
QNCX was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

QNCX Historical Analyst RatingsQNCX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.174.047.657.4010.50 - 245.30% 553.85% 532.05% 797.44%

Related screens

QNCX Current Analyst RatingQNCX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-03-25 D. Boral Capital Maintains Buy -> Buy
2025-03-24 Oppenheimer Initiate Outperform
2025-02-05 D. Boral Capital Maintains Buy -> Buy
2025-01-02 D. Boral Capital Maintains Buy -> Buy
2024-12-18 Brookline Capital Initiate Buy
2024-11-14 D. Boral Capital Maintains Buy -> Buy
2024-11-12 D. Boral Capital Maintains Buy -> Buy
2024-11-07 Maxim Group Initiate Buy
2024-10-29 Rodman & Renshaw Initiate Buy
2024-10-22 EF Hutton Initiate Buy